Patent details

Basic Information

Publication number:

EP2590997

PCT Application Number:

US2011043465

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP118044510

PCT Publication Number:

WO2012006598

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

STABILIZED INSULINOTROPIC PEPTIDES AND METHODS OF USE

French Title of Invention:

PEPTIDES INSULINOTROPES STABILISÉS ET PROCÉDÉS D'UTILISATION

German Title of Invention:

STABILISIERTE INSULINOTROPE PEPTIDE UND VERFAHREN ZU IHRER VERWENDUNG

SPC Number:

Dates

Filing date:

08/07/2011

Grant date:

04/04/2018

EP Publication Date:

15/05/2013

PCT Publication Date:

12/01/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/04/2018

EP B1 Publication Date:

04/04/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/07/2018

Expiration date:

08/07/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/03/2018

 

 

Name:

Dana-Farber Cancer Institute, Inc.

Address:

450 Brookline Avenue, Boston, MA 02215, United States (US)

Inventor

1

Name:

WALENSKY, Loren, D.

Address:

United States (US)

2

Name:

BIRD, Gregory

Address:

United States (US)

Priority

Priority Number:

363097 P

Priority Date:

09/07/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/22; A61K 38/26; A61P 3/10; C07K 14/575; C07K 14/605; C07K 14/62;

Publication

European Patent Bulletin

Issue number:

201814

Publication date:

04/04/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/11/2018	Outgoing Correspondence	1